The unified social credit code/registration number of Sinopharm Holdings Donghong Pharmaceutical (Shanghai) Co., Ltd. is 91310000132206860x, and the enterprise is in the opening state.
The business scope of Sinopharm Holdings Donghong Pharmaceutical (Shanghai) Co., Ltd. is: sales of Chinese patent medicines, chemical pharmaceutical preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, psychotropic drugs of category II (preparations), toxic drugs for medical use (botulinum toxin A for injection), protein assimilation preparations, peptide hormones, medical devices (operated by branches at higher levels), veterinary medical devices, medical dressings and disinfectants. Projects that are subject to approval according to law can only carry out business activities after being approved by relevant departments. In Shanghai, the total registered capital of companies with similar business scope is 9,707.35 million yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million yuan, 1 0,000-10,000,000, * * * 1 999. In the province, the registered capital of enterprises is excellent.
Sinopharm Holdings Donghong Pharmaceutical (Shanghai) Co., Ltd. invested in 0 companies, 1 branch.
See more information and materials of Sinopharm Holdings Donghong Medicine (Shanghai) Co., Ltd. through Baidu Enterprise Credit.